Martina Dester
Cremona, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Addendum: Impact of BMI on the outcome of metastatic breast cancer patients treated with everolimus: a retrospective exploratory analysis of the BALLET study.
Journal: Oncotarget
Published: December 06, 2022
Early Changes of the Standardized Uptake Values (SUVmax) Predict the Efficacy of Everolimus-Exemestane in Patients with Hormone Receptor-Positive Metastatic Breast Cancer.
Journal: Cancers
Published: September 23, 2020
ΔKi67 proliferation index as independent predictive and prognostic factor of outcome in luminal breast cancer: data from neoadjuvant letrozole-based treatment.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: June 04, 2020
Impact of BMI on the outcome of metastatic breast cancer patients treated with everolimus: a retrospective exploratory analysis of the BALLET study.
Journal: Oncotarget
Published: January 08, 2020
CDK4/6 inhibitors in HER2-positive breast cancer.
Journal: Critical reviews in oncology/hematology
Published: November 23, 2016
Are EGFR tyrosine kinase inhibitors effective in elderly patients with EGFR-mutated non-small cell lung cancer?
Journal: Clinical and experimental medicine
Published: October 24, 2016
Low-Dose Oral Ethinylestradiol With Concomitant Low-Dose Acetylsalicylic Acid for Advanced Castrate-Resistant Prostate Cancer.
Journal: Clinical genitourinary cancer
Published: July 07, 2016
A Phase II study of olaparib in breast cancer patients: biological evaluation from a 'window of opportunity' trial.
Journal: Future oncology (London, England)
Published: June 22, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026